These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29559307)

  • 1. Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TB.
    Proaño A; Bui DP; López JW; Vu NM; Bravard MA; Lee GO; Tracey BH; Xu Z; Comina G; Ticona E; Mollura DJ; Friedland JS; Moore DAJ; Evans CA; Caligiuri P; Gilman RH;
    Chest; 2018 Jun; 153(6):1358-1367. PubMed ID: 29559307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Proaño A; Bravard MA; López JW; Lee GO; Bui D; Datta S; Comina G; Zimic M; Coronel J; Caviedes L; Cabrera JL; Salas A; Ticona E; Vu NM; Kirwan DE; Loader MI; Friedland JS; Moore DAJ; Evans CA; Tracey BH; Gilman RH;
    Clin Infect Dis; 2017 May; 64(9):1174-1181. PubMed ID: 28329268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for studying cough frequency in people with pulmonary tuberculosis.
    Proaño A; Bravard MA; Tracey BH; López JW; Comina G; Zimic M; Coronel J; Lee GO; Caviedes L; Cabrera JL; Salas A; Ticona E; Kirwan DE; Friedland JS; Evans CA; Moore DA; Gilman RH;
    BMJ Open; 2016 Apr; 6(4):e010365. PubMed ID: 27105713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided detection and quantification of cavitary tuberculosis from CT scans.
    Xu Z; Bagci U; Kubler A; Luna B; Jain S; Bishai WR; Mollura DJ
    Med Phys; 2013 Nov; 40(11):113701. PubMed ID: 24320475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cough dynamics in adults receiving tuberculosis treatment.
    Lee GO; Comina G; Hernandez-Cordova G; Naik N; Gayoso O; Ticona E; Coronel J; Evans CA; Zimic M; Paz-Soldan VA; Gilman RH; Oberhelman R
    PLoS One; 2020; 15(6):e0231167. PubMed ID: 32511248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis.
    Theron G; Limberis J; Venter R; Smith L; Pietersen E; Esmail A; Calligaro G; Te Riele J; de Kock M; van Helden P; Gumbo T; Clark TG; Fennelly K; Warren R; Dheda K
    Nat Med; 2020 Sep; 26(9):1435-1443. PubMed ID: 32601338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis.
    Suzuki T; Shirai T; Hirai K; Tanaka Y; Watanabe H; Endo Y; Shimoda Y; Saigusa M; Akamatsu T; Yamamoto A; Morita S; Asada K
    Respir Investig; 2019 May; 57(3):252-259. PubMed ID: 30738923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis.
    Perrin FM; Woodward N; Phillips PP; McHugh TD; Nunn AJ; Lipman MC; Gillespie SH
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1596-602. PubMed ID: 21144246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.
    Johnson JL; Vjecha MJ; Okwera A; Hatanga E; Byekwaso F; Wolski K; Aisu T; Whalen CC; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1998 May; 2(5):397-404. PubMed ID: 9613636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smear-negative, culture-positive pulmonary tuberculosis among patients with chronic cough in Cotonou, Benin.
    Affolabi D; Akpona R; Odoun M; Alidjinou K; Wachinou P; Anagonou S; Gninafon M; Trébucq A
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):67-70. PubMed ID: 21276299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis.
    Takasaka N; Seki Y; Fujisaki I; Uchiyama S; Matsubayashi S; Sato A; Yamanaka Y; Odashima K; Kazuyori T; Seki A; Takeda H; Ishikawa T; Kuwano K
    BMC Pulm Med; 2020 Nov; 20(1):287. PubMed ID: 33160360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
    Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
    BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting.
    Huerga H; Varaine F; Okwaro E; Bastard M; Ardizzoni E; Sitienei J; Chakaya J; Bonnet M
    PLoS One; 2012; 7(12):e51336. PubMed ID: 23284681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.